Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1091-1097

  Klein, Matthias ^a   Vaeth, Martin ^b   Scheel, Tobias ^c   Grabbe, Stephan ^a   Baumgrass, Ria ^c   Berberich Siebelt, Friederike ^b   Bopp, Tobias ^a   Schmitt, Edgar ^a   Becker, Christian ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; PHOSPHODIESTERASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CLONAL ANERGY; CYCLIC AMP; HUMANS; MICE; NFATC TRANSCRIPTION FACTORS; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 84856574460     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102045     Document Type: Article

References (47)

1. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244. (Pubitemid 351267321)
2. Thornton, A. M., and E. M. Shevach. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296. (Pubitemid 28357757)
3. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9: 222-229.
4. Francis, S. H., and J. D. Corbin. 1999. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci. 36: 275-328. (Pubitemid 29431414)
5. Bopp, T., C. Becker, M. Klein, S. Klein-Hessling, A. Palmetshofer, E. Serfling, V. Heib, M. Becker, J. Kubach, S. Schmitt, et al. 2007. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204: 1303-1310. (Pubitemid 46919868)
6. Fassbender, M., B. Gerlitzki, N. Ullrich, C. Lupp, M. Klein, M. P. Radsak, E. Schmitt, T. Bopp, and H. Schild. 2010. Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cell. Immunol. 265: 91-96.
7. Bodor, J., A. L. Spetz, J. L. Strominger, and J. F. Habener. 1996. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc. Natl. Acad. Sci. USA 93: 3536-3541. (Pubitemid 26125656)
8. Foulkes, N. S., B. M. Laoide, F. Schlotter, and P. Sassone-Corsi. 1991. Transcriptional antagonist cAMP-responsive element modulator (CREM) downregulates c-fos cAMP-induced expression. Proc. Natl. Acad. Sci. USA 88: 5448-5452. (Pubitemid 21914762)
9. Hoeffler, J. P., T. E. Meyer, Y. Yun, J. L. Jameson, and J. F. Habener. 1988. Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. Science 242: 1430-1433. (Pubitemid 19008071)
10. Bodor, J., L. Feigenbaum, J. Bodorova, C. Bare, M. S. J. Reitz, Jr., and R. E. Gress. 2001. Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J. Leukoc. Biol. 69: 1053-1059. (Pubitemid 32577910)
11. Bodor, J., Z. Fehervari, B. Diamond, and S. Sakaguchi. 2007. Regulatory T cell-mediated suppression: potential role of ICER. J. Leukoc. Biol. 81: 161-167. (Pubitemid 46021265)
12. Fassi Fehri, L., M. Koch, E. Belogolova, H. Khalil, C. Bolz, B. Kalali, H. J. Mollenkopf, M. Beigier-Bompadre, A. Karlas, T. Schneider, et al. 2010. Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS ONE 5: e9500.
13. Gri, G., S. Piconese, B. Frossi, V. Manfroi, S. Merluzzi, C. Tripodo, A. Viola, S. Odom, J. Rivera, M. P. Colombo, and C. E. Pucillo. 2008. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29: 771-781.
14. Huang, B., J. Zhao, Z. Lei, S. Shen, D. Li, G. X. Shen, G. M. Zhang, and Z. H. Feng. 2009. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 10: 180-185.
15. Jain, N., H. Nguyen, R. H. Friedline, N. Malhotra, M. Brehm, M. Koyanagi, M. Bix, J. A. Cooper, C. A. Chambers, and J. Kang. 2009. Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function. J. Immunol. 183: 4192-4196.
16. Kuczma, M., J. R. Lee, and P. Kraj. 2011. Connexin 43 signaling enhances the generation of Foxp3+ regulatory T cells. J. Immunol. 187: 248-257.
17. Oberle, N., N. Eberhardt, C. S. Falk, P. H. Krammer, and E. Suri-Payer. 2007. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J. Immunol. 179: 3578-3587.
18. Becker, C., C. Taube, T. Bopp, C. Becker, K. Michel, J. Kubach, S. Reuter, N. Dehzad, M. F. Neurath, K. Reifenberg, et al. 2009. Protection from graftversus- host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. Blood 114: 1263-1269.
19. Bopp, T., N. Dehzad, S. Reuter, M. Klein, N. Ullrich, M. Stassen, H. Schild, R. Buhl, E. Schmitt, and C. Taube. 2009. Inhibition of cAMP degradation improves regulatory T cell-mediated suppression. J. Immunol. 182: 4017-4024.
20. Jonuleit, H., and E. Schmitt. 2005. Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells. Methods Mol. Med. 109: 285-296.
21. Lippe, C., and C. Ardizzone. 1991. Actions of vasopressin and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenyl cyclase inhibitors MDL12330A and SQ22536. Comp. Biochem. Physiol. C. 99: 209-211.
22. Beavo, J. A., and L. L. Brunton. 2002. Cyclic nucleotide research - still expanding after half a century. Nat. Rev. Mol. Cell Biol. 3: 710-718. (Pubitemid 34987792)
23. Bjørgo, E., and K. Taskén. 2006. Role of cAMP phosphodiesterase 4 in regulation of T-cell function. Crit. Rev. Immunol. 26: 443-451. (Pubitemid 44785490)
24. Houslay, M. D., and D. R. Adams. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370: 1-18. (Pubitemid 36259414)
25. Serfling, E., F. Berberich-Siebelt, S. Chuvpilo, E. Jankevics, S. Klein-Hessling, T. Twardzik, and A. Avots. 2000. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim. Biophys. Acta 1498: 1-18.
26. Nayak, A., J. Glöckner-Pagel, M. Vaeth, J. E. Schumann, M. Buttmann, T. Bopp, E. Schmitt, E. Serfling, and F. Berberich-Siebelt. 2009. Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J. Biol. Chem. 284: 10935-10946.
27. Vaeth, M., T. Gogishvili, T. Bopp, M. Klein, F. Berberich-Siebelt, S. Gattenloehner, A. Avots, T. Sparwasser, N. Grebe, E. Schmitt, et al. 2011. Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proc. Natl. Acad. Sci. USA 108: 2480-2485.
28. Ledbetter, J. A., M. Parsons, P. J. Martin, J. A. Hansen, P. S. Rabinovitch, and C. H. June. 1986. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J. Immunol. 137: 3299-3305. (Pubitemid 17181705)
29. Skålhegg, B. S., A. M. Rasmussen, K. Taskén, V. Hansson, T. Jahnsen, and T. Lea. 1994. Cyclic AMP sensitive signalling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex. Scand. J. Immunol. 40: 201-208. (Pubitemid 24251738)
30. Vendetti, S., M. Patrizio, A. Riccomi, and M. T. De Magistris. 2006. Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP. J. Leukoc. Biol. 80: 880-888. (Pubitemid 44835906)
31. Kress, A. K., G. Schneider, K. Pichler, M. Kalmer, B. Fleckenstein, and R. Grassmann. 2010. Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1. J. Virol. 84: 8732-8742.
32. Gavin, M. A., T. R. Torgerson, E. Houston, P. DeRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103: 6659-6664.
33. Bazhin, A. V., S. Kahnert, S. Kimpfler, D. Schadendorf, and V. Umansky. 2010. Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells. Mol. Immunol. 47: 678-684.
34. Aandahl, E. M., W. J. Moretto, P. A. Haslett, T. Vang, T. Bryn, K. Tasken, and D. F. Nixon. 2002. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 169: 802-808. (Pubitemid 34753436)
35. Oviedo-Orta, E., T. Hoy, and W. H. Evans. 2000. Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations. Immunology 99: 578-590. (Pubitemid 30201005)
36. van Rijen, H. V., T. A. van Veen, M. M. Hermans, and H. J. Jongsma. 2000. Human connexin40 gap junction channels are modulated by cAMP. Cardiovasc. Res. 45: 941-951.
37. Szymczak-Workman, A. L., C. J. Workman, and D. A. Vignali. 2009. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J. Immunol. 182: 5188-5192.
38. Nishi, A., M. Kuroiwa, D. B. Miller, J. P. O'Callaghan, H. S. Bateup, T. Shuto, N. Sotogaku, T. Fukuda, N. Heintz, P. Greengard, and G. L. Snyder. 2008. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J. Neurosci. 28: 10460-10471.
39. Mongillo, M., T. McSorley, S. Evellin, A. Sood, V. Lissandron, A. Terrin, E. Huston, A. Hannawacker, M. J. Lohse, T. Pozzan, et al. 2004. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ. Res. 95: 67-75. (Pubitemid 38931837)
40. Hoffmann, P., R. Eder, T. J. Boeld, K. Doser, B. Piseshka, R. Andreesen, and M. Edinger. 2006. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108: 4260-4267. (Pubitemid 44913302)
41. Battaglia, M., A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M. G. Roncarolo. 2006. Rapamycin promotes expansion of functional CD4 +CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177: 8338-8347. (Pubitemid 44893795)
42. Beckner, S. K., and W. L. Farrar. 1987. Inhibition of adenylate cyclase by IL 2 in human T lymphocytes is mediated by protein kinase C. Biochem. Biophys. Res. Commun. 145: 176-182. (Pubitemid 17088421)
43. Zhou, X., S. L. Bailey-Bucktrout, L. T. Jeker, C. Penaranda, M. Martínez-Llordella, M. Ashby, M. Nakayama, W. Rosenthal, and J. A. Bluestone. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10: 1000-1007.
44. Oldenhove, G., N. Bouladoux, E. A. Wohlfert, J. A. Hall, D. Chou, L. Dos Santos, S. O'Brien, R. Blank, E. Lamb, S. Natarajan, et al. 2009. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772-786.
45. Aricha, R., T. Feferman, M. C. Souroujon, and S. Fuchs. 2006. Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor. FASEB J. 20: 374-376. (Pubitemid 46671176)
46. Raskovalova, T., A. Lokshin, X. Huang, Y. Su, M. Mandic, H. M. Zarour, E. K. Jackson, and E. Gorelik. 2007. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling. Cancer Res. 67: 5949-5956. (Pubitemid 46985031)
47. Su, Y., X. Huang, T. Raskovalova, L. Zacharia, A. Lokshin, E. Jackson, and E. Gorelik. 2008. Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression. Cancer Immunol. Immunother. 57: 1611-1623.